DIA Biosimilars 2013

PharmaNet

inVentiv Health completes PharmaNet acquisition

Thursday, July 14, 2011 12:56 PM

Burlington, Mass.-based inVentiv Health, which offering clinical, commercial and consulting services to the healthcare industry, has completed the acquisition of CRO PharmaNet Development Group. Financial terms of the transaction were not disclosed.

More... »

Cenduit: Now with Patient Reminders

PharmaNet names Dr. Joel Posener executive medical director, neuroscience

Wednesday, June 29, 2011 12:47 PM

PharmaNet Development Group, a provider of clinical development services, has named Joel Posener, M.D., Executive Medical Director, Neuroscience.

More... »

CRF Health – eCOA Forum

Standards Council of Canada recognizes PharmaNet lab

Wednesday, June 29, 2011 12:28 PM

PharmaNet Development Group, a provider of drug development services, said its bioanalytical laboratory in Quebec City, Canada, has received formal recognition from the Standards Council of Canada (SCC) for its compliance with the Organization for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practice (GLP).

More... »

inVentiv Health completes i3 acquisition

Monday, June 13, 2011 09:56 AM

inVentiv Health has completed the acquisition of CRO i3. i3, previously owned by Ingenix, a UnitedHealth Group company.

More... »

PharmaNet Canada to partner with HMR

Friday, May 27, 2011 11:51 AM

PharmaNet Development Group, a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced that its subsidiary, PharmaNet Canada, and Maisonneuve-Rosemont  Hospital (HMR) and its research center, will collaborate to conduct pharmacokinetic studies in patients with impaired renal function.

More... »

CRO consolidation craze continues as inVentiv scoops up PharmaNet, propelling it into top tier

Monday, May 23, 2011 08:40 AM

The Pac Man game continues, with mid-tier CROs being acquired or buying one another on an almost weekly basis.

More... »

inVentiv Health to acquire PharmaNet

Tuesday, May 17, 2011 10:54 AM

InVentiv Health, a service provider to the healthcare industry, has signed a definitive agreement to purchase CRO PharmaNet Development Group. Financial terms of the transaction were not disclosed.

More... »

Valerie Palumbo joins PharmaNet

Thursday, April 28, 2011 01:01 PM

PharmaNet Development, a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, has appointed Valerie Palumbo to serve as senior vice president, corporate quality assurance.

More... »

Dr. Jeffrey Freitag named chief medical officer of PharmaNet

Tuesday, March 8, 2011 10:57 AM

PharmaNet Development Group, a provider of pharmaceutical services to biotechnology, generic drug and medical device companies, has promoted Jeffrey Freitag, M.D., senior vice president of PharmaNet Consulting, to chief medical officer.

More... »

PharmaNet in collaboration with Abacus International

Wednesday, July 28, 2010 07:48 AM

PharmaNet Development Group, a global contract research organization (CRO), announced a strategic collaboration with Abacus International, one of the largest independent health economic consultancies in Europe.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs